{"protocolSection": {"identificationModule": {"nctId": "NCT00345592", "orgStudyIdInfo": {"id": "2005_TH"}, "organization": {"fullName": "Boston Scientific Corporation", "class": "INDUSTRY"}, "briefTitle": "TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients", "officialTitle": "TReatment of Atrial Fibrillation With Dual dEfibrillator in Heart Failure Patients", "acronym": "TRADE HF"}, "statusModule": {"statusVerifiedDate": "2017-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2006-10"}, "primaryCompletionDateStruct": {"date": "2012-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2012-11", "type": "ACTUAL"}, "studyFirstSubmitDate": "2006-06-27", "studyFirstSubmitQcDate": "2006-06-27", "studyFirstPostDateStruct": {"date": "2006-06-28", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-04-04", "resultsFirstSubmitQcDate": "2014-05-13", "resultsFirstPostDateStruct": {"date": "2014-06-11", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2017-02-27", "lastUpdatePostDateStruct": {"date": "2017-03-28", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Boston Scientific Corporation", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "Demonstrate the efficacy of the device-based managed therapy to treat atrial tachycardia and fibrillation (AT/AF) in patients with CHF indication for implant of a CRT defibrillator and to demonstrate the advantage of automatic electrical therapy of atrial arrhythmias compared to an in-hospital approach for treatment of symptomatic AT/AF."}, "conditionsModule": {"conditions": ["Heart Failure, Congestive"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 420, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Device managed arm", "type": "EXPERIMENTAL", "description": "Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.", "interventionNames": ["Device: Dual (atrial and ventricular) implantable defibrillator"]}, {"label": "Traditional arm", "type": "ACTIVE_COMPARATOR", "description": "Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.", "interventionNames": ["Device: Dual (atrial and ventricular) implantable defibrillator"]}], "interventions": [{"type": "DEVICE", "name": "Dual (atrial and ventricular) implantable defibrillator", "description": "The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed.", "armGroupLabels": ["Device managed arm"]}, {"type": "DEVICE", "name": "Dual (atrial and ventricular) implantable defibrillator", "description": "In hospital application of anti arrhythmic therapies via the device", "armGroupLabels": ["Traditional arm"]}, {"type": "DEVICE", "name": "Dual (atrial and ventricular) implantable defibrillator", "description": "Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment", "armGroupLabels": ["Traditional arm"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Unplanned Hospital Admissions for Cardiac Reasons OR Death of Cardiovascular Causes OR Progression to Chronic Atrial Fibrillation", "timeFrame": "3 years from randomization (39 months total)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* chronic symptomatic HF despite stable, optimal drug therapy\n* indication for a cardiac resynchronisation device with defibrillator backup according to current guidelines\n* patients implanted with cardiac resynchronization device with dual (atrial and ventricular) defibrillation capabilities\n\nExclusion Criteria:\n\n* Chronic atrial fibrillation\n* Valvular disease\n* patients who underwent or are planned for ablation of atrial fibrillation\n* cerebral vascular accident/transient ischemic attack within 12 months from implant which lead to relevant impairment\n* preexisting unipolar pacemaker", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Gianluca Botto, MD", "affiliation": "Azienda Ospedale S. Anna", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Luigi Padeletti, MD", "affiliation": "Istituto di Clinica Medica I\u00b0 e Cardiologia A.O.C. Careggi", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Istituto di Clinica Medica I\u00b0 e Cardiologia A.O.C.", "city": "Careggi", "country": "Italy", "geoPoint": {"lat": 43.81284, "lon": 11.25097}}, {"facility": "Azienda Ospedale S. Anna", "city": "San Fermo della Battaglia (CO)", "country": "Italy"}]}, "referencesModule": {"references": [{"pmid": "21324118", "type": "DERIVED", "citation": "Botto GL, Boriani G, Favale S, Landolina M, Molon G, Tondo C, Biffi M, Grandinetti G, De Filippo P, Raciti G, Padeletti L. Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial. Trials. 2011 Feb 15;12:44. doi: 10.1186/1745-6215-12-44."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "24 subjects were not randomized:\n\n* 7 died before randomization (causes: 3 cardiac, 2 non-cardiac, 2 unknown);\n* 7 voluntarily withdrew;\n* 5 withdrawn due to AF.\n* 2 had device explanted before randomization;\n* 1 had biventricular pacing turned OFF\n* 1 was withdrawn from the study for inclusion criteria violation;\n* 1 lost to follow up.", "recruitmentDetails": "First patient was enrolled on the 3rd of October, 2006. Last patient was enrolled on the 29th of July 2009, for a total of 420 patients.", "groups": [{"id": "FG000", "title": "Device Managed Arm", "description": "Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.\n\nDual (atrial and ventricular) implantable defibrillator: The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed."}, {"id": "FG001", "title": "Traditional Arm", "description": "Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.\n\nDual (atrial and ventricular) implantable defibrillator: In hospital application of anti arrhythmic therapies via the device\n\nDual (atrial and ventricular) implantable defibrillator: Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "199"}, {"groupId": "FG001", "numSubjects": "197"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "174"}, {"groupId": "FG001", "numSubjects": "173"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "25"}, {"groupId": "FG001", "numSubjects": "24"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "14"}, {"groupId": "FG001", "numSubjects": "16"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "11"}, {"groupId": "FG001", "numSubjects": "8"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Device Managed Arm", "description": "Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.\n\nDual (atrial and ventricular) implantable defibrillator: The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed."}, {"id": "BG001", "title": "Traditional Arm", "description": "Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.\n\nDual (atrial and ventricular) implantable defibrillator: In hospital application of anti arrhythmic therapies via the device\n\nDual (atrial and ventricular) implantable defibrillator: Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "199"}, {"groupId": "BG001", "value": "197"}, {"groupId": "BG002", "value": "396"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "67", "spread": "10"}, {"groupId": "BG001", "value": "68", "spread": "10"}, {"groupId": "BG002", "value": "67", "spread": "10"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "47"}, {"groupId": "BG001", "value": "38"}, {"groupId": "BG002", "value": "85"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "152"}, {"groupId": "BG001", "value": "159"}, {"groupId": "BG002", "value": "311"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Italy", "categories": [{"measurements": [{"groupId": "BG000", "value": "199"}, {"groupId": "BG001", "value": "197"}, {"groupId": "BG002", "value": "396"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Unplanned Hospital Admissions for Cardiac Reasons OR Death of Cardiovascular Causes OR Progression to Chronic Atrial Fibrillation", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "3 years from randomization (39 months total)", "groups": [{"id": "OG000", "title": "Device Managed Arm", "description": "Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.\n\nDual (atrial and ventricular) implantable defibrillator: The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed."}, {"id": "OG001", "title": "Traditional Arm", "description": "Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.\n\nDual (atrial and ventricular) implantable defibrillator: In hospital application of anti arrhythmic therapies via the device\n\nDual (atrial and ventricular) implantable defibrillator: Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "199"}, {"groupId": "OG001", "value": "197"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "43"}, {"groupId": "OG001", "value": "44"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "paramType": "Hazard Ratio (HR)", "paramValue": "0.987", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.684", "ciUpperLimit": "1.503"}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Device Managed Arm", "description": "Device-managed therapy arm. Shock therapy for atrial arrhythmias is delivered automatically from the device.\n\nDual (atrial and ventricular) implantable defibrillator: The devices automatically applies therapy (shock) for atrial fibrillation, when atrial fibrillation is confirmed.", "seriousNumAffected": 103, "seriousNumAtRisk": 199, "otherNumAffected": 39, "otherNumAtRisk": 199}, {"id": "EG001", "title": "Traditional Arm", "description": "Traditional therapy arm. In this arm, therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment. Therefore, patients who will experience symptoms at home, will refer to their center, eventually hospitalized and treated for atrial arrhythmias.\n\nDual (atrial and ventricular) implantable defibrillator: In hospital application of anti arrhythmic therapies via the device\n\nDual (atrial and ventricular) implantable defibrillator: Therapy for atrial arrhythmias will be delivered from the device through command of the physician and in a hospital environment", "seriousNumAffected": 93, "seriousNumAtRisk": 197, "otherNumAffected": 22, "otherNumAtRisk": 197}], "seriousEvents": [{"term": "atrial fibrillation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 11, "numAffected": 10, "numAtRisk": 199}, {"groupId": "EG001", "numEvents": 9, "numAffected": 7, "numAtRisk": 197}]}, {"term": "worsening of cardiac disorders", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "events leading to death", "stats": [{"groupId": "EG000", "numEvents": 16, "numAffected": 16, "numAtRisk": 199}, {"groupId": "EG001", "numEvents": 14, "numAffected": 14, "numAtRisk": 197}]}, {"term": "hopspitalizatin/intervention", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "including cardiac and non cardiac hospitalizations", "stats": [{"groupId": "EG000", "numEvents": 85, "numAffected": 78, "numAtRisk": 199}, {"groupId": "EG001", "numEvents": 74, "numAffected": 58, "numAtRisk": 197}]}, {"term": "transplant", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 199}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 197}]}, {"term": "worsening of non-cardiac disorders", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "events leading to death", "stats": [{"groupId": "EG000", "numEvents": 8, "numAffected": 8, "numAtRisk": 199}, {"groupId": "EG001", "numEvents": 10, "numAffected": 10, "numAtRisk": 197}]}, {"term": "worsening of unknown conditions leading to death", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "include all the events leading to out of hospital death for unknown or undetermined conditions", "stats": [{"groupId": "EG000", "numEvents": 13, "numAffected": 13, "numAtRisk": 199}, {"groupId": "EG001", "numEvents": 7, "numAffected": 7, "numAtRisk": 197}]}], "otherEvents": [{"term": "device reprogramming", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "need to change device settings due to patient sysmptoms or adverse device effect, without invasive intervention", "stats": [{"groupId": "EG000", "numEvents": 17, "numAffected": 16, "numAtRisk": 199}, {"groupId": "EG001", "numEvents": 15, "numAffected": 14, "numAtRisk": 197}]}, {"term": "clinical observation", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "not requiring intervention", "stats": [{"groupId": "EG000", "numEvents": 24, "numAffected": 24, "numAtRisk": 199}, {"groupId": "EG001", "numEvents": 8, "numAffected": 8, "numAtRisk": 197}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Giovanni Luca Botto", "organization": "S. Anna Hospital", "email": "gluca.botto@gmail.com", "phone": "0315851", "phoneExt": "+39"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000001281", "term": "Atrial Fibrillation"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000001145", "term": "Arrhythmias, Cardiac"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M4586", "name": "Atrial Fibrillation", "asFound": "Atrial Fibrillation", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M4453", "name": "Arrhythmias, Cardiac", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"browseLeaves": [{"id": "M4213", "name": "Anti-Arrhythmia Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AnArAg", "name": "Anti-Arrhythmia Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}